Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA Methylation Patterns Associated with Tinnitus in Young Adults-A Pilot Study. | J Assoc Res Otolaryngol | 2024 | 39147981 | PubTator, text mining | PubMed |
| [ALK rearranged Spitz melanocytoma: a clinicopathological and molecular genetic analysis of two cases]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 39103263 | PubTator, text mining | PubMed |
| NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors. | Acta Neuropathol Commun | 2024 | 39014476 | PubTator, text mining | PubMed |
| Peptosome: A New Efficient Transfection Tool as an Alternative to Liposome. | Int J Mol Sci | 2024 | 39000028 | PubTator, text mining | PubMed |
Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland. | Acta Oncol | 2024 | 38967220 | PubTator, text mining | PubMed |
| Spitz Melanoma With SLC20A1::ALK Fusion: A Novel Fusion Previously Undescribed in Spitz Melanocytic Neoplasm. | Am J Dermatopathol | 2024 | 38941542 | PubTator, text mining | PubMed |
| The Role of TPM3 in Protecting Cardiomyocyte from Hypoxia-Induced Injury via Cytoskeleton Stabilization. | Int J Mol Sci | 2024 | 38928503 | PubTator, text mining | PubMed |
| Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway. | Cancer Med | 2024 | 38923428 | PubTator, text mining | PubMed |
| Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics. | EBioMedicine | 2024 | 38878676 | PubTator, text mining | PubMed |
| Feasibility of two-step approach for screening NTRK fusion in two major subtypes of non-small cell lung cancer within a large cohort. | Hum Pathol | 2024 | 38866255 | PubTator, text mining | PubMed |
| ALK-Rearranged Renal Cell Carcinoma: A Multi-Institutional Study of 9 Cases With Expanding the Morphologic and Molecular Genetic Spectrum. | Mod Pathol | 2024 | 38852815 | PubTator, text mining | PubMed |
| Identification of hub genes related to metastasis and prognosis of osteosarcoma and establishment of a prognostic model with bioinformatic methods. | Medicine (Baltimore) | 2024 | 38847690 | PubTator, text mining | PubMed |
| Difficulties of Preoperative Diagnosis of Cribriform Morular Thyroid Carcinoma. | Case Rep Endocrinol | 2024 | 38835742 | PubTator, text mining | PubMed |
| Oligomerization of drug transporters: Forms, functions, and mechanisms. | Acta Pharm Sin B | 2024 | 38799641 | PubTator, text mining | PubMed |
| Anchored-fusion enables targeted fusion search in bulk and single-cell RNA sequencing data. | Cell Rep Methods | 2024 | 38503288 | PubTator, text mining | PubMed |
| Sarcomeric tropomyosin expression during human iPSC differentiation into cardiomyocytes. | Cytoskeleton (Hoboken) | 2024 | 38470291 | PubTator, text mining | PubMed |
| Identification and validation of protein biomarkers for predicting gastrointestinal stromal tumor recurrence. | Comput Struct Biotechnol J | 2024 | 38455069 | PubTator, text mining | PubMed |
| Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review. | J Cutan Pathol | 2024 | 38444194 | PubTator, text mining | PubMed |
| Case report: Adult NTRK-rearranged spindle cell neoplasms with TPM3-NTRK1 fusion in the pelvic. | Front Oncol | 2024 | 38357202 | PubTator, text mining | PubMed |
| Cerebrospinal fluid proteomic signatures are associated with symptom severity of first-episode psychosis. | J Psychiatr Res | 2024 | 38340697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=8